Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease

RC Welsh, ED Peterson, R De Caterina, C Bode… - American heart …, 2019 - Elsevier
For 4 decades, antithrombotic therapy with aspirin has been a cornerstone of secondary
prevention for patients with chronic atherosclerotic cardiovascular disease (ASCVD) …

Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.

RC Welsh, ED Peterson, R De Caterina… - American Heart …, 2019 - europepmc.org
For 4 decades, antithrombotic therapy with aspirin has been a cornerstone of secondary
prevention for patients with chronic atherosclerotic cardiovascular disease (ASCVD) …

Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease

RC Welsh, ED Peterson… - American …, 2019 - utsouthwestern.elsevierpure.com
For 4 decades, antithrombotic therapy with aspirin has been a cornerstone of secondary
prevention for patients with chronic atherosclerotic cardiovascular disease (ASCVD) …

[引用][C] Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease

RC Welsh, ED Peterson, R De Caterina… - AMERICAN HEART …, 2019 - arpi.unipi.it
Applying contemporary antithrombotic therapy in the secondary prevention of chronic
atherosclerotic cardiovascular disease IRIS IRIS Home Sfoglia Macrotipologie & tipologie …

Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease

RC Welsh, ED Peterson… - American heart …, 2019 - pubmed.ncbi.nlm.nih.gov
For 4 decades, antithrombotic therapy with aspirin has been a cornerstone of secondary
prevention for patients with chronic atherosclerotic cardiovascular disease (ASCVD) …